TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Testing Delivery Channels of Brief Motivational Alcohol Intervention Among General Hospital Inpatients With Risky Drinking: Personal Counseling Versus Computer-generated Feedback Letters
Brief Summary: The aim of this study is to investigate whether motivation-tailored alcohol interventions are more effective when delivered by person or by computer-generated feedback letters. A sample of 920 general hospital inpatients with risky drinking will be recruited through a computerized screening procedure. Patients with more severe alcohol problems will be excluded from the study. Participants will be allocated by time frame randomization to one of three study arms: (1) personal counseling based on Motivational Interviewing, (2) computer-expert system intervention that generates individualized feedback-letters, and (3) control group (treatment-as-usual). The interventions differ in their channel of delivery, but not regarding their content. Both intervention groups receive interventions at three time points: directly after the baseline-assessment at the general hospital, and 1 and 3 months later by mail and phone, respectively. Outcome will be assessed six, 12, 18 and 24 months after baseline.


Options:
A: Intervention Type: DRUG; Name: Treatment of depression; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Suicide prevention intervention; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Suicide prevention treatment; Assigned to Arm(s): N/A
B: Arm Label: Routine data collection; Type: ACTIVE_COMPARATOR; Interventions: Other: Routine Data collection | Arm Label: Feedback of patient-reported outcomes; Type: EXPERIMENTAL; Interventions: Other: Routine Data collection, Other: Feedback of patient-reported outcomes | Intervention Type: OTHER; Name: Routine Data collection; Assigned to Arm(s): Feedback of patient-reported outcomes, Routine data collection | Intervention Type: OTHER; Name: Feedback of patient-reported outcomes; Assigned to Arm(s): Feedback of patient-reported outcomes
C: Arm Label: PCI Group; Type: OTHER; Interventions: Other: Patient Concerns Inventory | Arm Label: Non PCI Group; Type: OTHER; Interventions: Other: No Patient Concerns Inventory | Intervention Type: OTHER; Name: Patient Concerns Inventory; Assigned to Arm(s): PCI Group | Intervention Type: OTHER; Name: No Patient Concerns Inventory; Assigned to Arm(s): Non PCI Group
D: Arm Label: Personal counseling; Type: EXPERIMENTAL; Interventions: Behavioral: Personal Counseling | Arm Label: Computer generated feedback letters; Type: EXPERIMENTAL; Interventions: Behavioral: Computer-generated feedback letters | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Personal Counseling; Assigned to Arm(s): Personal counseling | Intervention Type: BEHAVIORAL; Name: Computer-generated feedback letters; Assigned to Arm(s): Computer generated feedback letters

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Efficacy of a Intervention to Reduce Medication Errors and Therapeutic Failure in Patients Over 65 Years Polypharmacy
Brief Summary: The purpose of this study is to demonstrate that an intervention based on the motivational interview directed to patients with polypharmacy to improve the Therapeutic Adherence and to reduce the errors of Medication in major measure that the habitual intervention.


Options:
A: Arm Label: Motivational interview; Type: EXPERIMENTAL; Interventions: Behavioral: Motivational interview | Intervention Type: BEHAVIORAL; Name: Motivational interview; Assigned to Arm(s): Motivational interview
B: Arm Label: Reciprocal Diabetes Peer Support program; Type: EXPERIMENTAL; Interventions: Behavioral: Reciprocal Diabetes Peer Support Program, Behavioral: group outpatient counseling visits | Arm Label: Nurse Case Management; Type: OTHER; Interventions: Behavioral: Nurse Case management | Intervention Type: BEHAVIORAL; Name: Reciprocal Diabetes Peer Support Program; Assigned to Arm(s): Reciprocal Diabetes Peer Support program | Intervention Type: BEHAVIORAL; Name: Nurse Case management; Assigned to Arm(s): Nurse Case Management | Intervention Type: BEHAVIORAL; Name: group outpatient counseling visits; Assigned to Arm(s): Reciprocal Diabetes Peer Support program
C: Arm Label: STRIP intervention; Type: EXPERIMENTAL; Interventions: Other: STRIP intervention | Arm Label: Control; Type: SHAM_COMPARATOR; Interventions: Other: Control | Intervention Type: OTHER; Name: STRIP intervention; Assigned to Arm(s): STRIP intervention | Intervention Type: OTHER; Name: Control; Assigned to Arm(s): Control
D: Arm Label: PATCH Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: PATCH intervention | Arm Label: Usual Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual care | Intervention Type: BEHAVIORAL; Name: PATCH intervention; Assigned to Arm(s): PATCH Intervention | Intervention Type: BEHAVIORAL; Name: Usual care; Assigned to Arm(s): Usual Care

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Efficacy of a Intervention to Reduce Medication Errors and Therapeutic Failure in Patients Over 65 Years Polypharmacy
Brief Summary: The purpose of this study is to demonstrate that an intervention based on the motivational interview directed to patients with polypharmacy to improve the Therapeutic Adherence and to reduce the errors of Medication in major measure that the habitual intervention.


Options:
A: Arm Label: ISTOP-ADE; Type: EXPERIMENTAL; Interventions: Other: ISTOP-ADE | Arm Label: Routine care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: ISTOP-ADE; Assigned to Arm(s): ISTOP-ADE
B: Arm Label: Intervention Arm; Type: EXPERIMENTAL; Interventions: Other: EHR Based Strategy to promote Safe and Appropriate Drug Use | Arm Label: Standard Care Arm; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: EHR Based Strategy to promote Safe and Appropriate Drug Use; Assigned to Arm(s): Intervention Arm
C: Arm Label: Usual care; Type: PLACEBO_COMPARATOR; Interventions: Other: Usual care | Arm Label: Usual care + feedback of practice performance; Type: ACTIVE_COMPARATOR; Interventions: Other: Feedback of Performance | Arm Label: Usual care + feedback + health psychology intervention; Type: ACTIVE_COMPARATOR; Interventions: Other: Feedback of Performance + Health Psychology Informed Intervention | Intervention Type: OTHER; Name: Usual care; Assigned to Arm(s): Usual care | Intervention Type: OTHER; Name: Feedback of Performance; Assigned to Arm(s): Usual care + feedback of practice performance | Intervention Type: OTHER; Name: Feedback of Performance + Health Psychology Informed Intervention; Assigned to Arm(s): Usual care + feedback + health psychology intervention
D: Arm Label: Motivational interview; Type: EXPERIMENTAL; Interventions: Behavioral: Motivational interview | Intervention Type: BEHAVIORAL; Name: Motivational interview; Assigned to Arm(s): Motivational interview

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Pentoxifylline Treatment in Acute Pancreatitis; A Double-Blind Placebo-Controlled Randomized Trial
Brief Summary: The purpose of this study is to determine the effects (good and bad) of giving a drug called pentoxifylline to patients with acute pancreatitis, to see if it can improve blood tests associated with inflammation (tissue damage). Pentoxifylline is approved by the US Food and Drug Administration (FDA) for treatment of circulation problems, but its use in this study is investigational, which means that the FDA has not approved it for the treatment of pancreatitis. However, the FDA has allowed the use of pentoxifylline in this research study.


Options:
A: Arm Label: Activated protein C; Type: EXPERIMENTAL; Interventions: Drug: Activated protein C | Intervention Type: DRUG; Name: Activated protein C; Assigned to Arm(s): Activated protein C
B: Arm Label: Pentoxifylline; Type: EXPERIMENTAL; Interventions: Drug: Pentoxifylline | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Pentoxifylline; Assigned to Arm(s): Pentoxifylline | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Indomethacin | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo suppositories | Intervention Type: DRUG; Name: Indomethacin; Assigned to Arm(s): 1 | Intervention Type: OTHER; Name: Placebo suppositories; Assigned to Arm(s): 2
D: Arm Label: Lipidem® (BBraun); Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Lipidem (Omega-3 fish oil lipid emulsion) | Arm Label: Lipofundin® MCT/LCT 20%; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Lipofundin® MCT/LCT 20% | Intervention Type: DIETARY_SUPPLEMENT; Name: Lipidem (Omega-3 fish oil lipid emulsion); Assigned to Arm(s): Lipidem® (BBraun) | Intervention Type: DIETARY_SUPPLEMENT; Name: Lipofundin® MCT/LCT 20%; Assigned to Arm(s): Lipofundin® MCT/LCT 20%

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: PROMIS - Prostate MRI Imaging Study - Evaluation of Multi-Parametric Magnetic Resonance Imaging in the Diagnosis and Characterization of Prostate Cancer
Brief Summary: RATIONALE: Diagnostic procedures, such as magnetic resonance imaging (MRI), may help find prostate cancer and learn the extent of disease.

PURPOSE: This clinical trial is studying the safety of MRI and to see how well it works in diagnosing prostate cancer.


Options:
A: Intervention Type: OTHER; Name: biologic sample preservation procedure; Assigned to Arm(s): N/A | Intervention Type: OTHER; Name: laboratory biomarker analysis; Assigned to Arm(s): N/A | Intervention Type: OTHER; Name: study of socioeconomic and demographic variables; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: diffusion-weighted magnetic resonance imaging; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: dynamic contrast-enhanced magnetic resonance imaging; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: multiparametric magnetic resonance imaging; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: quality-of-life assessment; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: transperineal prostate biopsy; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: transrectal prostate biopsy; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: ultrasound-guided prostate biopsy; Assigned to Arm(s): N/A
B: Arm Label: MRI; Type: EXPERIMENTAL; Interventions: Device: 3T MRI (Magnetom Verio 3T, Erlangen, Germany), Device: Transrectal ultrasound (Bk Medical Pro Focus Ultraview 2202 system) | Intervention Type: DEVICE; Name: 3T MRI (Magnetom Verio 3T, Erlangen, Germany); Assigned to Arm(s): MRI | Intervention Type: DEVICE; Name: Transrectal ultrasound (Bk Medical Pro Focus Ultraview 2202 system); Assigned to Arm(s): MRI
C: Arm Label: Prostate biopsy; Type: OTHER; Interventions: Procedure: Prostate biopsy | Intervention Type: PROCEDURE; Name: Prostate biopsy; Assigned to Arm(s): Prostate biopsy
D: Arm Label: All cohorts (prostate biopsy percutaneous biopsy and ablation); Type: EXPERIMENTAL; Interventions: Device: EM Tracking | Intervention Type: DEVICE; Name: EM Tracking; Assigned to Arm(s): All cohorts (prostate biopsy percutaneous biopsy and ablation)

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Lunch in the Bag: Packing More Fruit, Vegetables, Grain in Preschool Sack Lunches
Brief Summary: Lunch is in the Bag is an intervention designed to increase fruits, vegetables, and whole grains in sack lunches prepared for preschool children. Lunch is in the Bag includes 5 weeks of parent handouts, classroom activities related to topics in the handouts, parent and child activities to reinforce behavioral constructs, and a one week booster 22 weeks later.

The primary study hypothesis is that Lunch is in the Bag will increase fruit, vegetables, and whole grains in sack lunches. Additional hypotheses are that lunches at child care centers where the program is used will have higher dietary quality than centers without the program and that children at the centers where the program is used will have a smaller increase in body mass index than children at centers with the program.

The study will also look at the child's home environment and the childcare center. Hypotheses for this research question include

1. Children at centers with Lunch is in the Bag will have greater frequency of eating fruits, vegetables, and whole grains at home than those at centers without the program.
2. Compared to parents at centers without the program, parents of children at centers with Lunch is in the Bag will have

   1. Greater knowledge, expected benefits, support, intentions, and belief in their ability for packing fruit, vegetables, and whole grain in their child's sack lunch daily.
   2. Availability of fruit, vegetable, and whole grain in the home pantry.
   3. Number of lunches with temperature in the safe range at time of service.


Options:
A: Intervention Type: BEHAVIORAL; Name: Nutritional and life style counseling; Assigned to Arm(s): N/A
B: Arm Label: Intervention arm; Type: EXPERIMENTAL; Interventions: Behavioral: Healthy Start | Arm Label: Control arm; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Healthy Start; Assigned to Arm(s): Intervention arm
C: Arm Label: Low intensity arm; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Dietary, physical activity and sleeping | Arm Label: High intensity arm; Type: EXPERIMENTAL; Interventions: Behavioral: Dietary, physical activity and sleeping | Intervention Type: BEHAVIORAL; Name: Dietary, physical activity and sleeping; Assigned to Arm(s): High intensity arm, Low intensity arm
D: Arm Label: Lunch in the Bag Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Lunch is in the Bag behavioral intervention | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Lunch is in the Bag behavioral intervention; Assigned to Arm(s): Lunch in the Bag Intervention

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Lunch in the Bag: Packing More Fruit, Vegetables, Grain in Preschool Sack Lunches
Brief Summary: Lunch is in the Bag is an intervention designed to increase fruits, vegetables, and whole grains in sack lunches prepared for preschool children. Lunch is in the Bag includes 5 weeks of parent handouts, classroom activities related to topics in the handouts, parent and child activities to reinforce behavioral constructs, and a one week booster 22 weeks later.

The primary study hypothesis is that Lunch is in the Bag will increase fruit, vegetables, and whole grains in sack lunches. Additional hypotheses are that lunches at child care centers where the program is used will have higher dietary quality than centers without the program and that children at the centers where the program is used will have a smaller increase in body mass index than children at centers with the program.

The study will also look at the child's home environment and the childcare center. Hypotheses for this research question include

1. Children at centers with Lunch is in the Bag will have greater frequency of eating fruits, vegetables, and whole grains at home than those at centers without the program.
2. Compared to parents at centers without the program, parents of children at centers with Lunch is in the Bag will have

   1. Greater knowledge, expected benefits, support, intentions, and belief in their ability for packing fruit, vegetables, and whole grain in their child's sack lunch daily.
   2. Availability of fruit, vegetable, and whole grain in the home pantry.
   3. Number of lunches with temperature in the safe range at time of service.


Options:
A: Arm Label: Mobile phone based intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Mobile phone based intervention | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Mobile phone based intervention; Assigned to Arm(s): Mobile phone based intervention
B: Arm Label: HOME Plus Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: HOME Plus intervention | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: HOME Plus intervention; Assigned to Arm(s): HOME Plus Intervention
C: Arm Label: Lunch in the Bag Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Lunch is in the Bag behavioral intervention | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Lunch is in the Bag behavioral intervention; Assigned to Arm(s): Lunch in the Bag Intervention
D: Arm Label: Optimisation + HENRY; Type: EXPERIMENTAL; Interventions: Behavioral: Optimisation + HENRY | Arm Label: HENRY as standard; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: HENRY as standard | Intervention Type: BEHAVIORAL; Name: Optimisation + HENRY; Assigned to Arm(s): Optimisation + HENRY | Intervention Type: BEHAVIORAL; Name: HENRY as standard; Assigned to Arm(s): HENRY as standard

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Controlled Trial of 2% Lidocaine Gel for IUD Insertion
Brief Summary: The intrauterine device (IUD) is a long-acting, highly effective, reversible contraceptive that may be underutilized due to fear of pain during insertion. Although providers frequently prescribe non-steroidal anti-inflammatory drugs (NSAIDs) for IUD insertion, there is no evidence for any pain reduction. In fact, no interventions evaluated in randomized controlled trials have been shown to be effective in reducing pain during IUD insertion. While many women tolerate IUD insertion well, others have moderate to severe pain. This double-blind randomized controlled trial of 150 women aims to estimate the efficacy of intracervical 2% lidocaine gel compared to placebo (KY jelly) to reduce IUD insertion pain. Our hypothesis is that women who are treated with 2% lidocaine gel prior to IUD insertion will have reduced pain as measured on a 0 mm to 100 mm Visual Analog Scale (VAS). We will be able to detect a 15 mm difference on the VAS with our sample size. Other data to be collected include information regarding age, BMI, obstetric history, lactation status, time since pregnancy or delivery, last menstrual period, history of cervical conization, anxiety levels, anticipated pain levels, insertion characteristics (time, difficulty, complications), side effects, and satisfaction with pain control. If 2% lidocaine gel is effective, then a viable, easily administered option for pain control will be available to providers and patients.


Options:
A: Arm Label: misoprostol; Type: EXPERIMENTAL; Interventions: Drug: Misoprostol | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Misoprostol; Assigned to Arm(s): misoprostol | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: misoprostol; Type: EXPERIMENTAL; Interventions: Drug: Misoprostol | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Misoprostol; Assigned to Arm(s): misoprostol | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): placebo
C: Arm Label: Misoprostol; Type: EXPERIMENTAL; Interventions: Drug: Misoprostol | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Misoprostol; Assigned to Arm(s): Misoprostol | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Control Group; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo gel | Arm Label: Study Group; Type: EXPERIMENTAL; Interventions: Drug: 2% lidocaine gel | Intervention Type: DRUG; Name: 2% lidocaine gel; Assigned to Arm(s): Study Group | Intervention Type: DRUG; Name: Placebo gel; Assigned to Arm(s): Control Group

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase III, Multicenter, Randomized, Double-blind, Dose-ranging, Placebo-controlled Study to Evaluate the Efficacy, Response Duration and Safety of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU)/Chronic Spontaneous Urticaria Who Remain Symptomatic Despite Antihistamine Treatment (H1)
Brief Summary: The study is a global Phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of omalizumab administered subcutaneously as an add-on therapy for the treatment of adolescent and adult patients aged 12-75 who have been diagnosed with refractory CIU and who remain symptomatic despite standard-dosed H1 antihistamine treatment.


Options:
A: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: desloratadine | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: desloratadine | Intervention Type: DRUG; Name: desloratadine; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: desloratadine; Assigned to Arm(s): 2
B: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Levocetirizine; Type: EXPERIMENTAL; Interventions: Drug: Levocetirizine | Intervention Type: DRUG; Name: Levocetirizine; Assigned to Arm(s): Levocetirizine | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Arm Label: Levocetirizine; Type: EXPERIMENTAL; Interventions: Drug: Levocetirizine 1.25 mg | Intervention Type: DRUG; Name: Levocetirizine 1.25 mg; Assigned to Arm(s): Levocetirizine | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Placebo; Type: EXPERIMENTAL; Interventions: Drug: Placebo, Drug: Omalizumab | Arm Label: Omalizumab 75 mg; Type: EXPERIMENTAL; Interventions: Drug: Omalizumab | Arm Label: Omalizumab 150 mg; Type: EXPERIMENTAL; Interventions: Drug: Omalizumab | Arm Label: Omalizumab 300 mg; Type: EXPERIMENTAL; Interventions: Drug: Omalizumab | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Omalizumab; Assigned to Arm(s): Omalizumab 150 mg, Omalizumab 300 mg, Omalizumab 75 mg, Placebo

Answer: D